A systematic review and meta-analysis published in Frontiers in Neurology has synthesized the fragmented evidence regarding gastrointestinal complications in adults with aneurysmal subarachnoid hemorrhage. The study, led by researchers from The Second Affiliated Hospital of Nanchang University, specifically focused on quantifying the incidence of gastrointestinal bleeding while narratively synthesizing data on other gastrointestinal issues such as constipation, diarrhea, and composite dysfunction. The primary finding indicates that the pooled incidence of study-defined inpatient gastrointestinal bleeding is 4.07%, with a 95% confidence interval ranging from 0.52% to 10.53%. This estimate is derived from five independent cohort studies involving a total of 2,824 patients and 145 bleeding events. The authors emphasize that this figure should be interpreted with caution due to the very low certainty of the evidence and persistent heterogeneity among the included studies.
The research team conducted a comprehensive search across nine databases, including PubMed, Embase, and the Cochrane Library, from inception until June 15, 2026. The review included cohort studies, cross-sectional studies, and case series that reported separately extractable data for adults with confirmed aneurysmal subarachnoid hemorrhage. After screening thousands of records, the investigators identified sixteen reports for inclusion in the systematic review. Of these, only five independent cohort studies provided sufficient data for the primary meta-analysis of gastrointestinal bleeding incidence. The remaining reports contributed to narrative syntheses of other gastrointestinal outcomes or were used in sensitivity analyses to test the robustness of the primary findings.
One of the central challenges identified in the review is the lack of standardized definitions for gastrointestinal bleeding across different studies. The diagnostic criteria varied significantly, ranging from overt bleeding signs to positive occult blood testing. For instance, one study defined bleeding as requiring transfusion or a specific decrease in hemoglobin, while another included any positive fecal occult blood test. These definitional differences likely contribute to the wide range of observed incidences, which spanned from 1.02% to 17.89% across the five studies included in the primary analysis. The high degree of statistical heterogeneity, indicated by an I-squared value of 97.74%, suggests that the true incidence may vary considerably depending on how bleeding is defined and detected in different clinical settings.
To address the influence of these varying definitions, the researchers performed sensitivity analyses. When they excluded two studies whose definitions included occult blood positivity, the pooled incidence dropped to 2.45%, with a 95% confidence interval of 0.43% to 5.90%. However, considerable heterogeneity persisted in this subset, with an I-squared value of 90.67%. Another sensitivity analysis replaced one study from the LongTEAM cohort with an alternative report from the same registry to assess the impact of potential participant overlap. This analysis yielded a pooled incidence of 4.42%, further highlighting the sensitivity of the results to study selection and definition choices. The authors note that these exploratory analyses were insufficient to reliably establish the primary sources of heterogeneity.
The study also examined factors associated with gastrointestinal bleeding, drawing from seven reports that used multivariable regression or propensity score matching. Observational findings suggested associations between bleeding and cerebral vasospasm, elevated intracranial pressure, and impaired renal function. For example, one study reported that cerebral vasospasm was associated with higher odds of clinically important gastrointestinal bleeding, with an odds ratio of 2.51. Another found that endovascular coiling was associated with a higher hazard of bleeding compared to surgical clipping, although this finding was not consistent across all studies. The authors stress that these are observational associations and do not establish causality, as residual confounding by indication and disease severity remains a significant limitation.
Beyond bleeding, the review addressed other gastrointestinal complications, including constipation, diarrhea, and composite gastrointestinal dysfunction. Evidence for these outcomes was limited and heterogeneous, precluding quantitative pooling. One study reported constipation in 74.38% of evaluable patients, defined as no bowel movement for three consecutive days. Another study found diarrhea in 11.43% of patients, defined by specific Bristol Stool Form Scale types. A separate study reported composite gastrointestinal dysfunction in 44.77% of patients, a definition that included a range of symptoms from vomiting to gastric residual volume issues. The authors emphasize that these distinct complications should be interpreted separately, as their predictors and clinical implications differ, and their frequencies cannot be combined into a single overall gastrointestinal complication rate.
The prognostic implications of these gastrointestinal complications were also synthesized narratively. Some studies reported associations between gastrointestinal bleeding and poor hospital outcomes, while others linked diarrhea to lower odds of a favorable functional outcome at discharge. However, these findings varied widely in terms of the specific outcomes measured, the effect estimates used, and the covariates adjusted for in the analyses. For instance, one study found no clear association between constipation and cerebral vasospasm, while another reported a strong unadjusted association between diarrhea and delayed ischemic neurological deficit. The authors caution that these associations do not establish causal effects, as gastrointestinal events may reflect underlying illness severity or treatment exposure rather than directly causing adverse outcomes.
Methodological quality assessments of the included studies revealed recurring limitations. Many cohorts excluded early deaths or patients with incomplete records, potentially introducing selection bias. Several reports lacked explicit diagnostic definitions or clearly described outcome ascertainment procedures. The certainty of evidence for the pooled bleeding incidence was rated as very low using the GRADE framework, primarily due to serious risk of bias and very serious inconsistency. The authors highlight that the small number of studies and the wide confidence intervals limit the precision and generalizability of the pooled estimate. This low certainty underscores the need for further research to clarify the true incidence and risk factors for gastrointestinal complications in this population.
The review concludes that the current evidence base for gastrointestinal complications in aneurysmal subarachnoid hemorrhage is fragmented and of low certainty. The pooled incidence of gastrointestinal bleeding should be interpreted cautiously, given the methodological limitations and persistent heterogeneity among the studies. The authors call for prospective multicenter studies that use standardized outcome definitions and ascertainment methods to improve the accuracy and comparability of future estimates. Such studies should also distinguish between occult positivity and clinically important bleeding, and record detailed information on severity, ulcer history, medication exposure, and event timing to better understand the underlying mechanisms and risk factors.
In summary, this systematic review provides a valuable synthesis of the available evidence on gastrointestinal complications in patients with aneurysmal subarachnoid hemorrhage. While it offers a preliminary estimate of the incidence of gastrointestinal bleeding, it also highlights the significant gaps and limitations in the current literature. The findings underscore the importance of recognizing and documenting gastrointestinal morbidity in this patient population, while also emphasizing the need for more rigorous and standardized research to guide clinical practice and improve patient outcomes. The study serves as a foundation for future investigations aimed at clarifying the occurrence, risk factors, and prognostic significance of these complications.
Beyond the primary pooling approach, the review evaluated how statistical modeling influenced the bleeding estimates. Fitting a binomial-normal generalized linear mixed model across the same five primary cohort studies produced a pooled gastrointestinal bleeding incidence of 2.96 percent, with a 95 percent confidence interval of 0.79 percent to 9.80 percent. The investigators also cataloged granular imaging and laboratory variables examined in individual multivariable models. For instance, one cohort reported that each single Hounsfield unit increase in right caudate computed tomography attenuation was associated with a reduced hazard of stress-related gastrointestinal bleeding, yielding a hazard ratio of 0.913. Conversely, an evaluation of systemic inflammatory markers found that admission white blood cell count quartiles showed no statistically significant association with stress ulcer bleeding after multivariable adjustment. In interpreting observed differences between surgical clipping and endovascular coiling, the authors noted that neurovascular guidelines mandate dual antiplatelet regimens for stent-assisted coiling and flow diversion rather than primary coiling, yet the primary reports lacked medication-adjusted analyses to clarify whether antiplatelet exposure accounted for the observed disparities.
The review also detailed dietary interventions and specific clinical exposures linked to broader gut dysfunction. In a retrospective cohort evaluating enteral feeding formulations, patients receiving an oligomeric formula had a lower frequency of watery stools compared with those given a polymeric formula, at 15.8 percent versus 34.3 percent, alongside a reduced frequency of any diarrhea, at 45.3 percent versus 66.7 percent. In a multivariable Fine-Gray competing risk model accounting for in-hospital mortality, several specific clinical factors were independently associated with an increased subdistribution hazard of composite gastrointestinal dysfunction. These exposures included nasojejunal tube use, which carried a subdistribution hazard ratio of 2.15, cardiac arrhythmia at 1.55, targeted temperature management at 1.46, severe neurological presentation defined as Hunt-Hess grade 4 or higher at 1.32, and gastrointestinal drug exposure at 1.32. Composite neurosurgical intervention showed no definitive association.
Finally, treatment timing and study methodology provided essential context for the overall findings. A propensity score-matched analysis of 2,658 patients found that securing aneurysms between 24 and 72 hours after hemorrhage onset was associated with lower odds of stress ulcer bleeding compared with treatment within the first 24 hours, yielding an odds ratio of 0.811. However, the investigators cautioned that this observational association reflects residual confounding rather than clinical justification for delaying aneurysm repair. Methodological evaluations using the Newcastle-Ottawa Scale rated seven cohort studies as high quality and seven as moderate quality, with scores spanning five to nine stars out of nine. The authors registered their protocol in the PROSPERO database and restricted inclusion strictly to adults with confirmed aneurysmal hemorrhage, noting that the resulting evidence cannot be generalized to patients experiencing non-aneurysmal subarachnoid hemorrhage.
Subject of Research: Gastrointestinal complications in patients with aneurysmal subarachnoid hemorrhage: a systematic review with meta-analysis of gastrointestinal bleeding incidence
Article Title: Gastrointestinal complications in patients with aneurysmal subarachnoid hemorrhage: a systematic review with meta-analysis of gastrointestinal bleeding incidence
Article References: Wu, T., Yang, H., Cao, M., Huang, C., He, T., & Gong, Y. (2026). Gastrointestinal complications in patients with aneurysmal subarachnoid hemorrhage: a systematic review with meta-analysis of gastrointestinal bleeding incidence. Frontiers in Neurology, 17, Article 1956555. https://doi.org/10.3389/fneur.2026.1956555
Image Credits: AI Generated
DOI: 10.3389/fneur.2026.1956555
Keywords: Gastrointestinal, complications, patients, aneurysmal, subarachnoid, hemorrhage, systematic, review, meta-analysis, bleeding, incidence
News Source: Cassandra Pierce. (November 14, 2026). Review Finds Wide Variability in Gut Bleeding After Brain Bleeds. Scienmag.



